Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced the establishment of its co-headquarters in Singapore, marking a major ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Aera Therapeutics, a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, today announced that ...

This granted U.S. patent represents an important milestone for JayaBio,” said Pawel Krysiak, President and Chief Executive Officer of Jaya Biosciences. “It underscores our commitment to addressing the ...

Gross margins in the third quarter of 2025 were approximately 48.5%, versus 54.9% in the third quarter of 2024; and non-GAAP ...

Orthocell appoints its second distributor in US$75 million Canadian market for flagship nerve repair device Remplir. ... Read ...

In a fractured world, our task is to build bridges, to meet cynicism with optimism, and to hold fast to the founding belief ...

NFL icon and Birmingham City minority owner Tom Brady has claimed that his dog, Junie, is a genetic clone of family pet Lua, ...

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management ...

The Global Developed Markets Equity composite rose 1.7% gross of fees in the third quarter, lagging the 7.4% gain in the MSCI ...

NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:00 ...